Loading…

Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation

Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2014-11, Vol.20 (21), p.5403-5411
Main Authors: Colliez, Florence, Neveu, Marie-Aline, Magat, Julie, Cao Pham, Thanh Trang, Gallez, Bernard, Jordan, Bénédicte F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13
cites cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13
container_end_page 5411
container_issue 21
container_start_page 5403
container_title Clinical cancer research
container_volume 20
creator Colliez, Florence
Neveu, Marie-Aline
Magat, Julie
Cao Pham, Thanh Trang
Gallez, Bernard
Jordan, Bénédicte F
description Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker. The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally. Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.
doi_str_mv 10.1158/1078-0432.CCR-13-3434
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1619317635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1619317635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</originalsourceid><addsrcrecordid>eNo9kN9LwzAQgIMobk7_BCWPvnTmmqRNH2X4Cwai6HPI0nRE22Qm7XD_vambwsEdx3d33IfQJZA5ABc3QEqREUbz-WLxmgHNKKPsCE2B8zKjecGPU_3HTNBZjB-EAAPCTtEk5zkRQsAUyZdBtbaxWvXWO-wbrLDzzrqtinZrcKfWzvRW42Cid8ppg23qWbfGK-s7FT5NwL3HKkYTI-6Hzgfsv3dr4343nqOTRrXRXBzyDL3f370tHrPl88PT4naZaUqqPqtVU7EcaMUKEKzUUIGooSkFFUXJNKd1AaB4CpWX2hhDCRRQQ7ECpRNJZ-h6v3cT_NdgYi87G7VpW-WMH6JMdEWhLChPKN-jOvgYg2nkJqSfwk4CkaNbOXqTozeZ3EqgcnSb5q4OJ4ZVZ-r_qT-Z9AeLHnXJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1619317635</pqid></control><display><type>article</type><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><source>Freely Accessible Journals</source><creator>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</creator><creatorcontrib>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</creatorcontrib><description>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker. The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally. Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-13-3434</identifier><identifier>PMID: 25208881</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Biomarkers, Tumor - chemistry ; Biomarkers, Tumor - metabolism ; Cell Line, Tumor ; Female ; Humans ; Lipids - chemistry ; Magnetic Resonance Imaging - methods ; Mice ; Mice, Nude ; Neoplasms - metabolism ; Oxygen - metabolism</subject><ispartof>Clinical cancer research, 2014-11, Vol.20 (21), p.5403-5411</ispartof><rights>2014 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</citedby><cites>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25208881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colliez, Florence</creatorcontrib><creatorcontrib>Neveu, Marie-Aline</creatorcontrib><creatorcontrib>Magat, Julie</creatorcontrib><creatorcontrib>Cao Pham, Thanh Trang</creatorcontrib><creatorcontrib>Gallez, Bernard</creatorcontrib><creatorcontrib>Jordan, Bénédicte F</creatorcontrib><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker. The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally. Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</description><subject>Animals</subject><subject>Biomarkers, Tumor - chemistry</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Female</subject><subject>Humans</subject><subject>Lipids - chemistry</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasms - metabolism</subject><subject>Oxygen - metabolism</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kN9LwzAQgIMobk7_BCWPvnTmmqRNH2X4Cwai6HPI0nRE22Qm7XD_vambwsEdx3d33IfQJZA5ABc3QEqREUbz-WLxmgHNKKPsCE2B8zKjecGPU_3HTNBZjB-EAAPCTtEk5zkRQsAUyZdBtbaxWvXWO-wbrLDzzrqtinZrcKfWzvRW42Cid8ppg23qWbfGK-s7FT5NwL3HKkYTI-6Hzgfsv3dr4343nqOTRrXRXBzyDL3f370tHrPl88PT4naZaUqqPqtVU7EcaMUKEKzUUIGooSkFFUXJNKd1AaB4CpWX2hhDCRRQQ7ECpRNJZ-h6v3cT_NdgYi87G7VpW-WMH6JMdEWhLChPKN-jOvgYg2nkJqSfwk4CkaNbOXqTozeZ3EqgcnSb5q4OJ4ZVZ-r_qT-Z9AeLHnXJ</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Colliez, Florence</creator><creator>Neveu, Marie-Aline</creator><creator>Magat, Julie</creator><creator>Cao Pham, Thanh Trang</creator><creator>Gallez, Bernard</creator><creator>Jordan, Bénédicte F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><author>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Biomarkers, Tumor - chemistry</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Female</topic><topic>Humans</topic><topic>Lipids - chemistry</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasms - metabolism</topic><topic>Oxygen - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colliez, Florence</creatorcontrib><creatorcontrib>Neveu, Marie-Aline</creatorcontrib><creatorcontrib>Magat, Julie</creatorcontrib><creatorcontrib>Cao Pham, Thanh Trang</creatorcontrib><creatorcontrib>Gallez, Bernard</creatorcontrib><creatorcontrib>Jordan, Bénédicte F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colliez, Florence</au><au>Neveu, Marie-Aline</au><au>Magat, Julie</au><au>Cao Pham, Thanh Trang</au><au>Gallez, Bernard</au><au>Jordan, Bénédicte F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>20</volume><issue>21</issue><spage>5403</spage><epage>5411</epage><pages>5403-5411</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker. The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally. Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</abstract><cop>United States</cop><pmid>25208881</pmid><doi>10.1158/1078-0432.CCR-13-3434</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2014-11, Vol.20 (21), p.5403-5411
issn 1078-0432
1557-3265
language eng
recordid cdi_proquest_miscellaneous_1619317635
source Freely Accessible Journals
subjects Animals
Biomarkers, Tumor - chemistry
Biomarkers, Tumor - metabolism
Cell Line, Tumor
Female
Humans
Lipids - chemistry
Magnetic Resonance Imaging - methods
Mice
Mice, Nude
Neoplasms - metabolism
Oxygen - metabolism
title Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Qualification%20of%20a%20noninvasive%20magnetic%20resonance%20imaging%20biomarker%20to%20assess%20tumor%20oxygenation&rft.jtitle=Clinical%20cancer%20research&rft.au=Colliez,%20Florence&rft.date=2014-11-01&rft.volume=20&rft.issue=21&rft.spage=5403&rft.epage=5411&rft.pages=5403-5411&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-13-3434&rft_dat=%3Cproquest_cross%3E1619317635%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1619317635&rft_id=info:pmid/25208881&rfr_iscdi=true